National Council for Prescription Drug Programs indexing - billing unit

Manufacturer: National Council for Prescription Drug Programs
Effective date: 2012-07-24
Label type: Indexing - Billing Unit
Version: 1
Source: full-release
Hydrated at: 2026-06-05 02:09:28

Label at a glance#

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
58468-0040-1	EA - Each	58468-0040	835fb52d-bc09-4d09-8f57-b0eb38bf598f	1	2012-07-24

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
58468-0040	58468-0040-1

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
103979	Fabrazyme	agalsidase beta	351(a)	Rx	2026-09-01

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Fabrazyme	AGALSIDASE BETA	Genzyme Corporation	988513ab-b06f-4dd0-93f7-d2d4531dcce4	2025-08-22	Boxed warning, Warnings, Adverse reactions	Exact identifier ndc (package): 58468-0040-1 ndc11 (package): 58468004001

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.